110 related articles for article (PubMed ID: 14626791)
1. Quality control assurance in national screening programmes for cervical cancer.
Hadwin RJ; Walker PG
Ann Acad Med Singap; 2003 Sep; 32(5):632-7. PubMed ID: 14626791
[TBL] [Abstract][Full Text] [Related]
2. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
Calvache AE
Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
[No Abstract] [Full Text] [Related]
3. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines.
Basu P; Nessa A; Majid M; Rahman JN; Ahmed T
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):131-4. PubMed ID: 20659365
[TBL] [Abstract][Full Text] [Related]
4. Cytopathology in Austria.
Breitenecker G; Dinges HP; Regitnig P; Wiener H; Vutuc Ch
Cytopathology; 2004 Apr; 15(2):113-8. PubMed ID: 15056173
[TBL] [Abstract][Full Text] [Related]
5. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
Cubie HA; Moore C; Waller M; Moss S;
J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
[TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
[TBL] [Abstract][Full Text] [Related]
7. The pitfalls of cervical cancer screening.
Sedlis A
Contrib Gynecol Obstet; 1991; 18():103-14. PubMed ID: 1657521
[No Abstract] [Full Text] [Related]
8. Cervical cancer screening in England.
Patnick J
Eur J Cancer; 2000 Nov; 36(17):2205-8. PubMed ID: 11072205
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology internal quality assurance--what are the national standards?
Slater D
Cytopathology; 1994 Aug; 5(4):207-10. PubMed ID: 7948756
[No Abstract] [Full Text] [Related]
10. Rationale and development of an on-line quality assurance programme for colposcopy in a population-based cervical screening setting in Italy.
Bucchi L; Cristiani P; Costa S; Schincaglia P; Garutti P; Sassoli de Bianchi P; Naldoni C; Olea O; Sideri M
BMC Health Serv Res; 2013 Jun; 13():237. PubMed ID: 23809615
[TBL] [Abstract][Full Text] [Related]
11. Impact of media reporting of cervical cancer in a UK celebrity on a population-based cervical screening programme.
MacArthur GJ; Wright M; Beer H; Paranjothy S
J Med Screen; 2011; 18(4):204-9. PubMed ID: 22156146
[TBL] [Abstract][Full Text] [Related]
12. External quality assessment in gynaecological cytology: The Trent Region experience. The Trent Regional Gynaecological Pathology Quality Assurance Group for the National Health Service Cervical Screening Programme.
Slater DN; Hewer EM; Melling SE; Rice S
Cytopathology; 2002 Aug; 13(4):206-19. PubMed ID: 12269893
[TBL] [Abstract][Full Text] [Related]
13. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
[No Abstract] [Full Text] [Related]
14. External quality assurance for cervical cytology in developing countries. Experience in Peru and Nicaragua.
Salvetto M; Sandiford P
Acta Cytol; 2004; 48(1):23-31. PubMed ID: 14969177
[TBL] [Abstract][Full Text] [Related]
15. Is proficiency testing in cervical cytology proficient?
Herbert A
J Clin Pathol; 1997 Jul; 50(7):536-7. PubMed ID: 9306928
[No Abstract] [Full Text] [Related]
16. [Cervical cancer screening. False negative smears].
Vassilakos P; De Marval F; Muñoz M
Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
[No Abstract] [Full Text] [Related]
17. Cervical screening in the UK and laboratory quality control in the context of the 2007 European guidelines.
Herbert A
Coll Antropol; 2007 Apr; 31 Suppl 2():41-6. PubMed ID: 17598504
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
Slater DN
Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
[No Abstract] [Full Text] [Related]
19. Quality control in cytopathology applied to screening for cervical carcinoma.
Marsan C
Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
[TBL] [Abstract][Full Text] [Related]
20. Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing.
Cuschieri K; Schuurman R; Coughlan S
Cytopathology; 2019 May; 30(3):273-280. PubMed ID: 30657615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
